Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Chemical Research in Toxicology
|
March 1, 1992
Effect of bovine serum albumin on the extent of ortho rearrangement of N-(sulfooxy)-2-fluorenylacetamide and of enzymatically activated N-hydroxy-2-fluorenylacetamide and on the binding of reactive esters to nucleic acids
R C Kolanczyk, H R Gutmann, I R Rutks
Chemical Research in Toxicology
|
March 1, 1991
The catalytic effect of bovine serum albumin on the ortho rearrangement of the potential ultimate carcinogen, N-(sulfooxy)-2-(acetylamino)fluorene, generated enzymatically from N-hydroxy-2-(acetylamino)fluorene and evidence for substrate specificity of the enzymatic sulfonation of arylhydroxamic acids
R C Kolanczyk, I R Rutks, H R Gutmann
BJU International
|
August 22, 2003
Trazodone for erectile dysfunction: a systematic review and meta-analysis
H A Fink, R MacDonald, I R Rutks, et al.
The Cochrane Database of Systematic Reviews
|
January 10, 2003
Terazosin for benign prostatic hyperplasia
T J Wilt, R W Howe, I R Rutks, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Chemical Research in Toxicology
|
March 1, 1992
Effect of bovine serum albumin on the extent of ortho rearrangement of N-(sulfooxy)-2-fluorenylacetamide and of enzymatically activated N-hydroxy-2-fluorenylacetamide and on the binding of reactive esters to nucleic acids
R C Kolanczyk, H R Gutmann, I R Rutks
Chemical Research in Toxicology
|
March 1, 1991
The catalytic effect of bovine serum albumin on the ortho rearrangement of the potential ultimate carcinogen, N-(sulfooxy)-2-(acetylamino)fluorene, generated enzymatically from N-hydroxy-2-(acetylamino)fluorene and evidence for substrate specificity of the enzymatic sulfonation of arylhydroxamic acids
R C Kolanczyk, I R Rutks, H R Gutmann
BJU International
|
August 22, 2003
Trazodone for erectile dysfunction: a systematic review and meta-analysis
H A Fink, R MacDonald, I R Rutks, et al.
The Cochrane Database of Systematic Reviews
|
January 10, 2003
Terazosin for benign prostatic hyperplasia
T J Wilt, R W Howe, I R Rutks, et al.
Page
of 1